Form 4: Neuronetics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
William Andrew Macan, an executive at Neuronetics, sold 12,175 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.
Summary
- On February 12, 2025, William Andrew Macan, EVP, GC, CCO and CS of Neuronetics, Inc., sold 12,175 shares of Neuronetics' common stock.
- The sales were executed to satisfy the reporting person's tax withholding obligation upon the vesting of a portion of a restricted stock unit award.
- The shares were sold at a weighted average price of $3.83, with individual transactions ranging from $3.74 to $3.96 per share.
- Following the transaction, Macan directly owns 388,647 shares of Neuronetics common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an executive's stock sale to cover tax obligations. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common occurrences in publicly traded companies. It provides transparency into the trading activities of company executives and their potential alignment with shareholder interests.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of transaction: Sale of 12,175 shares of common stock. |
| 02/14/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.